{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:33:34Z","timestamp":1783420414465,"version":"3.54.6"},"reference-count":26,"publisher":"Informa UK Limited","issue":"8","funder":[{"name":"National Science Center of Poland","award":["2018\/31\/B\/NZ7\/02909"],"award-info":[{"award-number":["2018\/31\/B\/NZ7\/02909"]}]},{"name":"Purine and Pyrimidine Society"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Nucleosides, Nucleotides &amp; Nucleic Acids"],"published-print":{"date-parts":[[2024,8,2]]},"DOI":"10.1080\/15257770.2024.2339952","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T12:55:40Z","timestamp":1713185740000},"page":"851-861","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Effects of nucleoside analogues, lipophilic prodrugs and elaidic acids on core signaling pathways in cancer cells"],"prefix":"10.1080","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9525-4374","authenticated-orcid":false,"given":"Marika A.","family":"Fra\u0144czak","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland"},{"name":"Department of Medical Oncology, Amsterdam University Medical Centers, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine","family":"van der Sande","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Amsterdam University Medical Centers, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7565-7504","authenticated-orcid":false,"given":"Elisa","family":"Giovannetti","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Amsterdam University Medical Centers, Amsterdam, The Netherlands"},{"name":"Fondazione Pisana per la Scienza, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5447-2877","authenticated-orcid":false,"given":"Godefridus J.","family":"Peters","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland"},{"name":"Department of Medical Oncology, Amsterdam University Medical Centers, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,4,15]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1368-7646(02)00002-X"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-016-3003-0"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2023.101117"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365520902745039"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/2040620714552615"},{"key":"e_1_3_3_7_1","first-page":"2944","article-title":"Antitumor Activity of P-4055 (Elaidic Acid-Cytarabine) Compared to Cytarabine in Metastatic and s.c. Human Tumor Xenograft Models","volume":"59","author":"Breist\u00f8l K.","year":"1999","unstructured":"Breist\u00f8l, K.; Balzarini, J.; Sandvold, M. L.; Myhren, F.; Martinsen, M.; De Clercq, E.; Fodstad, O. Antitumor Activity of P-4055 (Elaidic Acid-Cytarabine) Compared to Cytarabine in Metastatic and s.c. Human Tumor Xenograft Models. Cancer Res. 1999, 59, 2944\u20132949.","journal-title":"Cancer Res."},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-009-9377-7"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1081\/NCN-200027579"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-011-9756-8"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-015-2846-0"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.2174\/092986709789878229"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v7.i5.352"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.2174\/138945010790031009"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2021.100779"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.127375"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.3892\/ijo_00000499"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389450115666141107110321"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature25183"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.9857"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2019.01.013"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(91)90142-Z"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M009698200"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.17.10792"},{"key":"e_1_3_3_25_1","first-page":"3615","article-title":"Antitumor Activity of Elacytarabine Combined with Bevacizumab, Cetuximab and Trastuzumab in Human NSCLC Xenografts","volume":"33","author":"Bruheim S.","year":"2013","unstructured":"Bruheim, S.; Sandvold, M. L.; M\u00e6landsmo, G. M.; Fodstad, O. Antitumor Activity of Elacytarabine Combined with Bevacizumab, Cetuximab and Trastuzumab in Human NSCLC Xenografts. Anticancer Res. 2013, 33, 3615\u20133621.","journal-title":"Anticancer Res."},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.6190"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-016-0371-1"}],"container-title":["Nucleosides, Nucleotides &amp; Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15257770.2024.2339952","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T14:05:47Z","timestamp":1732197947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15257770.2024.2339952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,15]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8,2]]}},"alternative-id":["10.1080\/15257770.2024.2339952"],"URL":"https:\/\/doi.org\/10.1080\/15257770.2024.2339952","relation":{},"ISSN":["1525-7770","1532-2335"],"issn-type":[{"value":"1525-7770","type":"print"},{"value":"1532-2335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=lncn20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=lncn20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-02-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-31","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}